US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 25, 2026 (5 months ago)

Fluocinonide

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

What was recalled

Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-1

Recalling firm
Sun Pharmaceutical Industries INC
NDC code
51672-1386-1
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0475-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluocinonide recalls

See all
Class II · Moderate risk Ongoing

Fluocinonide

Reason Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Sun Pharmaceutical Industries INC NDC 51672-1386-3 D-0477-2026
Class II · Moderate risk Ongoing

Fluocinonide

Reason Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Sun Pharmaceutical Industries INC NDC 51672-1386-2 D-0476-2026
Class II · Moderate risk Terminated

Fluocinonide Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk Terminated

Fluocinonide Gel USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022
Class II · Moderate risk Terminated

Fluocinonide Cream USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-079-11 D-0683-2022